Brimonidine Tartrate
Brand name: Alphagan P
Rank #161 of 500 drugs by total cost
$98.8M
Total Cost
988,570
Total Claims
$98.8M
Total Cost
16,454
Prescribers
$100
Cost per Claim
257,029
Beneficiaries
1,772,260
30-Day Fills
$6,005
Avg Cost/Provider
60
Avg Claims/Provider
About Brimonidine Tartrate
Brimonidine Tartrate (sold as Alphagan P) was prescribed 988,570 times by 16,454 Medicare Part D providers in 2023, costing the program $98.8M. At $100 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 158 | Darunavir/Cobicistat (Prezcobix) | $99.7M | 38,374 |
| 159 | Tocilizumab (Actemra) | $99.5M | 24,891 |
| 160 | Omalizumab (Xolair) | $98.9M | 30,451 |
| 161 | Brimonidine Tartrate (Alphagan P) | $98.8M | 988,570 |
| 162 | Dexlansoprazole (Dexlansoprazole Dr) | $98.7M | 275,116 |
| 163 | Interferon Beta-1a (Avonex) | $98.3M | 11,314 |
| 164 | Guselkumab (Tremfya) | $97.1M | 7,102 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology